Articles
6939 result(s) for 'sepsis' within Critical Care
Page 14 of 139
-
Citation: Critical Care 2013 17(Suppl 4):P86
-
Chaotic nature of sepsis and multiple organ failure cannot be explained by linear statistical methods
Citation: Critical Care 2008 12:417 -
PK/PD of single-dose amikacin in emergency department patients with severe sepsis/shock: should we apply the ICU-based higher loading dose?
Citation: Critical Care 2015 19(Suppl 1):P118 -
The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
Citation: Critical Care 2000 3(Suppl 1):P108 -
Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
Citation: Critical Care 2009 13(Suppl 1):P352 -
Inclusion criteria in sepsis trials should include severity of organ dysfunction
Citation: Critical Care 2001 5(Suppl 1):P231 -
Biomarkers in sepsis: a systematic review
Citation: Critical Care 2015 19(Suppl 1):P50 -
A cohort study of routinely used sepsis biomarkers and 28-day mortality
Citation: Critical Care 2013 17(Suppl 2):P28 -
Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock
Citation: Critical Care 2007 11(Suppl 2):P319 -
Does early appropriate antibiotic therapy improve the outcome of severe sepsis or septic shock?
Citation: Critical Care 2009 13(Suppl 1):P320 -
Adipose tissue lactate clearance but not blood lactate clearance is associated with clinical outcome in severe sepsis or septic shock during the post-resuscitation period
Citation: Critical Care 2014 18(Suppl 1):P172 -
Compliance with the surviving sepsis guidelines: a review of South African intensive care units
Citation: Critical Care 2007 11(Suppl 2):P72 -
Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
Citation: Critical Care 2008 12(Suppl 5):P21 -
Pathogenesis of organ damage during sepsis. In vitro influence of lipopolysaccharides and cytokines on the microtubular system
Citation: Critical Care 1997 1(Suppl 1):P022 -
Microcirculatory changes caused by magnesium sulphate infusion in severe sepsis and septic shock
Citation: Critical Care 2009 13(Suppl 1):P248 -
Comparison of demographics and outcomes of patients with severe sepsis admitted to the ICU with or without septic shock
Citation: Critical Care 2013 17(Suppl 4):P48 -
Evaluation of knowledge of nurses in intensive care, semi-intensive care and ready for a private hospital of St Paul on sepsis
Citation: Critical Care 2011 15(Suppl 2):P11 -
Extracorporeal albumin dialysis in paediatric patients with sepsis and multiorgan dysfunction
Citation: Critical Care 2006 10(Suppl 1):P292 -
Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin)®
Citation: Critical Care 2003 7(Suppl 2):P021 -
Apparent heterogenity in splanchnic vascular response to norepinephrine during sepsis
Citation: Critical Care 2007 11(Suppl 2):P36 -
Platelet/leukocyte ratio as a predictor of mortality in patients with sepsis
Citation: Critical Care 2013 17(Suppl 4):P52 -
A follow-up study of severe sepsis/septic shock patients using echocardiography
Citation: Critical Care 2005 9(Suppl 1):P56 -
Importance of glycated hemoglobin in hyperglycemia diagnosis of patients with sepsis
Citation: Critical Care 2011 15(Suppl 2):P15 -
Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
Citation: Critical Care 2014 18(Suppl 1):P243 -
CCR2 drives neutrophil infiltration and elicits tissue damage in remote organs during sepsis
Citation: Critical Care 2010 14(Suppl 2):P23 -
Relation between temperature in the initial 24 hours in patients with severe sepsis or septic shock with mortality and length of stay in the ICU
Citation: Critical Care 2012 16(Suppl 1):P57 -
Molecular diagnosis of severe bacterial sepsis in children
Citation: Critical Care 2012 16(Suppl 3):P67 -
Microvascular oxygen transport abnormalities in experimental sepsis interpreted using a computational model
Citation: Critical Care 2004 8(Suppl 1):P67 -
Sepsis Brazil – early results: albumin and mortality rate in septic shock
Citation: Critical Care 2005 9(Suppl 1):P207 -
Sequential Organ Failure Assessment score trends and sepsis survival in a Brazilian university hospital intensive care unit
Citation: Critical Care 2007 11(Suppl 2):P465 -
Mitochondrial injury in sepsis
Citation: Critical Care 2007 11(Suppl 3):P17 -
Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
Citation: Critical Care 2009 13(Suppl 1):P283 -
Effects of propofol and midazolam on indocyanine green elimination assessed with LiMON for early sepsis patients
Citation: Critical Care 2010 14(Suppl 1):P488 -
Changes in MIF and thyroxine, in a clinically relevant large animal model of sepsis
Citation: Critical Care 2009 13(Suppl 4):P51 -
Delayed ICU admission with community-acquired severe sepsis greatly increases mortality and resource use
Citation: Critical Care 2011 15(Suppl 1):P211 -
VX-166, a novel potent small molecule caspase inhibitor, as a promising new treatment for sepsis
Citation: Critical Care 2006 10(Suppl 1):P152 -
Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
Citation: Critical Care 2002 6(Suppl 1):P135 -
Clinical impact of enhanced cytokine clearance with sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in patients with severe sepsis
Citation: Critical Care 2012 16(Suppl 1):P383 -
Feasibility of gene transfer with nonviral vectors in murine models of sepsis
Citation: Critical Care 2013 17(Suppl 4):P92 -
Cancer patients with sepsis admitted to a specialized onco-medical ICU: incidence, ICU course and outcome
Citation: Critical Care 2011 15(Suppl 3):P12 -
Association of IL-6 promoter polymorphism -174C/G with outcome in severe sepsis
Citation: Critical Care 2008 12(Suppl 2):P462 -
Response of coagulation and fibrinolysis system was different between older and nonolder patients with severe sepsis
Citation: Critical Care 2014 18(Suppl 1):P103 -
Genomic variations within matrix metalloproteinase-9 and severe sepsis
Citation: Critical Care 2009 13(Suppl 1):P354 -
Experimental wound healing in severe sepsis and septic shock in humans
Citation: Critical Care 2008 12(Suppl 2):P390 -
Increased endotoxin activity is associated with clinical deterioration in moderate-severity emergency department sepsis patients: a pilot study
Citation: Critical Care 2012 16(Suppl 3):P102 -
Antithrombin III and sepsis
Citation: Critical Care 2001 5:73701 -
The limitations of observational studies on the treatment of severe sepsis – authors' response
Citation: Critical Care 2002 6:548 -
Early IL-6 response in sepsis is correlated with mortality and severity score
Citation: Critical Care 2013 17(Suppl 2):P34 -
Soluble usokinase plasminogen activator receptor as a useful biomarker to define advent of sepsis in patients with multiple injuries
Citation: Critical Care 2012 16(Suppl 1):P24 -
Early course of microcirculatory perfusion in the eye and digestive tract during experimental sepsis
Citation: Critical Care 2012 16(Suppl 1):P203
Follow
- ISSN: 1364-8535 (electronic)